Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 46, Issue , 2013, Pages 161-169

  Kaur, Manreena ^a   Lagopoulos, Jim ^a   Lee, Rico Sze Chun ^a   Ward, Philip B ^b,c   Naismith, Sharon L ^a   Hickie, Ian B ^a   Hermens, Daniel F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c LIVERPOOL HOSPITAL   (Australia)

Author keywords

Bipolar; Disability; Longitudinal; Mismatch negativity; P3a; Schizophrenia

Indexed keywords

AGOMELATINE; AMISULPRIDE; ARIPIPRAZOLE; ASENAPINE; CITALOPRAM; CLOZAPINE; DEXAMPHETAMINE; DIAZEPAM; DULOXETINE; ESCITALOPRAM; FLUVOXAMINE; LAMOTRIGINE; LITHIUM; METHYLPHENIDATE; MODAFINIL; NORTRIPTYLINE; OLANZAPINE; PALIPERIDONE; PREGABALIN; QUETIAPINE; RISPERIDONE; SERTRALINE; TEMAZEPAM; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ADULT; AFFECTIVE PSYCHOSIS; AFFECTIVE SPECTRUM DISORDER; ARTICLE; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; INTELLIGENCE QUOTIENT; LEARNING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DEFICIENCY; MISMATCH NEGATIVITY; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PROGNOSIS; PSYCHOSIS; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SOCIAL AND OCCUPATIONAL FUNCTIONING ASSESSMENT SCALE; SOCIAL DISABILITY;

ANALYSIS OF VARIANCE; ANOVA; BIPOLAR; BPRS; BRIEF PSYCHIATRIC RATING SCALE; DISABILITY; EEG; ELECTRO-OCULOGRAM; ELECTROENCEPHALOGRAPHY; EOG; ERP; EVENT-RELATED POTENTIAL; FUP; HAMILTON DEPRESSIVE RATING SCALE; HDRS; LONGITUDINAL; MISMATCH NEGATIVITY; MMN; NON-FUP; P3A; PATIENTS WHO DID NOT RETURN FOR FOLLOW-UP; PATIENTS WHO RETURNED FOR FOLLOW-UP; RAVLT; REY AUDITORY VERBAL LEARNING TEST; SCHIZOPHRENIA; SOCIAL AND OCCUPATIONAL FUNCTIONING SCALE; SOFAS; TMT; TRAILS MAKING TEST; WHO DAS-II; WORLD HEALTH ORGANISATION DISABILITY ASSESSMENT SCHEDULE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; EVENT-RELATED POTENTIALS, P300; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MOOD DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84882773568     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.07.002     Document Type: Article

References (67)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders, fourth ed. text revision 2000, American Psychiatric Association, Washington DC.
2. Atkinson R.J., Michie P.T., Schall U. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biol Psychiatry 2012, 71:98-104.
3. Bodatsch M., Ruhrmann S., Wagner M., Muller R., Schultze-Lutter F., Frommann I., et al. Prediction of psychosis by mismatch negativity. Biol Psychiatry 2011, 69:959-966.
4. Bora E., Yucel M., Pantelis C. Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr Bull 2010, 36:36-42.
5. Brewer W.J., Edwards J., Anderson V., Robinson T., Pantelis C. Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biol Psychiatry 1996, 40:1021-1031.
6. Brockhaus-Dumke A., Tendolkar I., Pukrop R., Schultze-Lutter F., Klosterkotter J., Ruhrmann S. Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophr Res 2005, 73:297-310.
7. Catts S.V., Shelley A.M., Ward P.B., Liebert B., McConaghy N., Andrews S., et al. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am J Psychiatry 1995, 152:213-219.
8. Chitty K.M., Kaur M., Lagopoulos J., Hickie I.B., Hermens D.F. Alcohol use and mismatch negativity in young patients with psychotic disorder. Neuroreport 2011, 22:918-922.
9. Chwastiak L.A., Von Korff M. Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO DAS II) in a primary care setting. J Clin Epidemiol 2003, 56:507-514.
10. Dingemans P.M., Linszen D.H., Lenior M.E., Smeets R.M. Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E). Psychopharmacol 1995, 122:263-267.
11. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured clinical interview for DSM-IV-TR axis I disorders - non-patient edition (SCID-I/NP, 1 1/2007 revision) 2007, New York State Psychiatric Institution, New York.
12. Fisher D.J., Labelle A., Knott V.J. Auditory hallucinations and the P3a: attention-switching to speech in schizophrenia. Biol Psychol 2010, 85:417-423.
13. Friedman D., Cycowicz Y.M., Gaeta H. The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neurosci Biobehav Rev 2001, 25:355-373.
14. Goldman H.H., Skodol A.E., Lave T.R. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992, 149:1148-1156.
15. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
16. Hermens D.F., Ward P.B., Redoblado Hodge M.A., Kaur M., Naismith S.L., Hickie I.B. Impaired MMN/P3a complex in first episode psychosis: cognitive and psychosocial associations. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:822-829.
17. Hermens D.F., Redoblado Hodge M.A., Naismith S.L., Kaur M., Scott E., Hickie I.B. Neuropsychological clustering highlights cognitive differences in young people presenting with depressive symptoms. J Int Neuropsychol Soc 2011, 17:267-276.
18. Jahshan C., Cadenhead K.S., Rissling A.J., Kirihara K., Braff D.L., Light G.A. Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med 2012, 42:85-97.
19. Jahshan C., Wynn J.K., Mathis K.I., Altshuler L.L., Glahn D.C., Green M.F. Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia. Bipolar Disord 2012, 14:239-248.
20. Javitt D.C. Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia. Audiol Neurootol 2000, 5:207-215.
21. Javitt D.C., Spencer K.M., Thaker G.K., Winterer G., Hajos M. Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov 2008, 7:68-83.
22. Kaur M., Battisti R.A., Ward P.B., Ahmed A., Hickie I.B., Hermens D.F. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups. Schizophr Res 2011, 130:203-209.
23. Kaur M., Battisti R.A., Lagopoulos J., Ward P.B., Hickie I.B., Hermens D.F. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster. J Psychiatry Neurosci 2012, 37:313-321.
24. Kaur M., Lagopoulos J., Ward P.B., Watson T.L., Naismith S.L., Hickie I.B., et al. Mismatch negativity/P3a complex in young people with psychiatric disorders: a cluster analysis. PLoS One 2012, 7:e51871.
25. Kawakubo Y., Kasai K., Kudo N., Rogers M.A., Nakagome K., ltoh K., et al. Phonetic mismatch negativity predicts verbal memory deficits in schizophrenia. Neuroreport 2006, 17:1043-1046.
26. Kawakubo Y., Kamio S., Nose T., Iwanami A., Nakagome K., Fukuda M., et al. Phonetic mismatch negativity predicts social skills acquisition in schizophrenia. Psychiatry Res 2007, 152:261-265.
27. Kiang M., Light G.A., Prugh J., Coulson S., Braff D.L., Kutas M. Cognitive, neurophysiological, and functional correlates of proverb interpretation abnormalities in schizophrenia. J Int Neuropsychol Soc 2007, 13:653-663.
28. Korostenskaja M., Dapsys K., Siurkute A., Maciulis V., Ruksenas O., Kähkönen S. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:543-548.
29. Lagopoulos J., Gordon E., Barhamali H., Lim C.L., Li W.M., Clouston P., et al. Dysfunctions of automatic (P300a) and controlled (P300b) processing in Parkinson's disease. Neurol Res 1998, 20:5-10.
30. Lee R.S.C., Hermens D.F., Redoblado Hodge M.A., Naismith SL A.P.M., Kaur M., et al. Neuropsychological and socio-occupational functioning in young psychiatric outpatients: a longitudinal investigation. PLoS One 2013, 8:e58176.
31. Lepisto T., Soininen M., Ceponiene R., Almqvist F., Naatanen R., Aronen E.T. Auditory event-related potential indices of increased distractibility in children with major depression. Clin Neurophysiol 2004, 115:620-627.
32. Leung S., Croft R.J., Baldeweg T., Nathan P.J. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology (Berl) 2007, 194:443-451.
33. Light G.A., Braff D.L. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry 2005, 62:127-136.
34. Light G.A., Braff D.L. Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. Am J Psychiatry 2005, 162:1741-1743.
35. Light G.A., Swerdlow N.R., Braff D.L. Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci 2007, 19:1624-1632.
36. Light G.A., Swerdlow N.R., Rissling A.J., Radant A., Sugar C.A., Sprock J., et al. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. PLoS One 2012, 7:e39434.
37. Michie P.T. What has MMN revealed about the auditory system in schizophrenia?. Int J Psychophysiol 2001, 42:177-194.
38. Mondragón-Maya A., Solís-Vivanco R., León-Ortiz P., Rodríguez-Agudelo Y., Yáñez-Téllez G., Bernal-Hernández J., et al. Reduced P3a amplitudes in antipsychotic naïve first-episode psychosis patients and individuals at clinical high-risk for psychosis. J Psychiatr Res 2013, 47(6):755-761.
39. Mowszowski L., Hermens D.F., Diamond K., Norrie L., Hickie I.B., Lewis S.J., et al. Reduced mismatch negativity in mild cognitive impairment: associations with neuropsychological performance. J Alzheimers Dis 2012, 30:209-219.
40. Naatanen R. The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function. Behav Brain Sci 1990, 13:201-288.
41. Naatanen R., Paavilainen P., Rinne T., Alho K. The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clin Neurophysiol 2007, 118:2544-2590.
42. Naatanen R., Kujala T., Escera C., Baldeweg T., Kreegipuu K., Carlson S., et al. The mismatch negativity (MMN) - a unique window to disturbed central auditory processing in ageing and different clinical conditions. Clin Neurophysiol 2012, 123:424-458.
43. Naismith S.L., Mowszowski L., Ward P.B., Diamond K., Paradise M., Kaur M., et al. Reduced temporal mismatch negativity in late-life depression: an event-related potential index of cognitive deficit and functional disability?. J Affect Disord 2012, 138:71-78.
44. Niznikiewicz M.A., Spencer K.M., Dickey C., Voglmaier M., Seidman L.J., Shenton M.E., et al. Abnormal pitch mismatch negativity in individuals with schizotypal personality disorder. Schizophr Res 2009, 110:188-193.
45. Pekkonen E., Hirvonen J., Ahveninen J., Kahkonen S., Kaakkola S., Huttunen J., et al. Memory-based comparison process not attenuated by haloperidol: a combined MEG and EEG study. Neuroreport 2002, 13:177-181.
46. Pesa N., Hermens D.F., Battisti R.A., Kaur M., Hickie I.B., Solowij N. Delayed preattentional functioning in early psychosis patients with cannabis use. Psychopharmacology (Berl) 2012, 222:507-518.
47. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 2007, 118:2128-2148.
48. Salisbury D.F., Kuroki N., Kasai K., Shenton M.E., McCarley R.W. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 2007, 64:521-529.
49. Schall U., Catts S.V., Karayanidis F., Ward P.B. Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes: valid outcome prediction of clozapine therapy in a three-year follow-up. Int J Neuropsychopharmacol 1999, 2:83-93.
50. Scott E., Naismith S., Whitwell B., Hamilton B., Chudleigh C., Hickie I. Delivering youth-specific mental health services: the advantages of a collaborative, multi-disciplinary system. Australas Psychiatry 2009, 17:189-194.
51. Scott E.M., Hermens D.F., Glozier N., Naismith S.L., Guastella A.J., Hickie I.B. Targeted primary care-based mental health services for young Australians. Med J Aust 2012, 196:136-140.
52. Scott E.M., Hermens D.F., Naismith S.L., Guastella A.J., De Regt T., White D., et al. Distinguishing young people with emerging bipolar disorders from those with unipolar depression. J Affect Disord 2013, 144:208-215.
53. Semlitsch H.V., Anderer P., Schuster P., Presslich O. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 1986, 23:695-703.
54. Shelley A.M., Ward P.B., Catts S.V., Michie P.T., Andrews S., McConaghy N. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry 1991, 30:1059-1062.
55. Shin K.S., Kim J.S., Kang D.-H., Koh Y., Choi J.-S., O'Donnell B.F., et al. Pre-attentive auditory processing in ultra-high-risk for schizophrenia with magnetoencephalography. Biol Psychiatry 2009, 65:1071-1078.
56. Shinozaki N., Yabe H., Sato Y., Hiruma T., Sutoh T., Nashida T., et al. The difference in mismatch negativity between the acute and post-acute phase of schizophrenia. Biol Psychol 2002, 59:105-119.
57. Strauss E., Sherman E.M.S., Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary 2006, Oxford University Press, New York. 3rd ed.
58. Takahashi T., Malhi G.S., Wood S.J., Yucel M., Walterfang M., Kawasaki Y., et al. Gray matter reduction of the superior temporal gyrus in patients with established bipolar I disorder. J Affect Disord 2010, 123:276-282.
59. Takei Y., Kumano S., Hattori S., Uehara T., Kawakubo Y., Kasai K., et al. Preattentive dysfunction in major depression: a magnetoencephalography study using auditory mismatch negativity. Psychophysiol 2009, 46:52-61.
60. Takei Y., Kumano S., Maki Y., Hattori S., Kawakubo Y., Kasai K., et al. Preattentive dysfunction in bipolar disorder: a MEG study using auditory mismatch negativity. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:903-912.
61. Turetsky B.I., Bilker W.B., Siegel S.J., Kohler C.G., Gur R.E. Profile of auditory information-processing deficits in schizophrenia. Psychiatry Res 2009, 165:27-37.
62. Umbricht D., Javitt D., Novak G., Bates J., Pollack S., Lieberman J., et al. Effects of clozapine on auditory event-related potentials in schizophrenia. Biol Psychiatry 1998, 44:716-725.
63. Umbricht D., Javitt D., Novak G., Bates J., Pollack S., Lieberman J., et al. Effects of risperidone on auditory event-related potentials in schizophrenia. Int J Neuropsychopharmacol 1999, 2:299-304.
64. Velakoulis D., Pantelis C., McGorry P.D., Dudgeon P., Brewer W., Cook M., et al. Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry 1999, 56:133-141.
65. Ventura J., Green M.F., Shaner A., Liberman R.P. Training and quality assurance with the Brief Psychiatric Rating Scale: "the drift busters". Int J Methods Psychiatr Res 1993, 3:221-244.
66. Wechsler D. Wechsler test of adult reading 2001, Psychological Corporation, San Antonio, TX.
67. Wynn J.K., Sugar C., Horan W.P., Kern R., Green M.F. Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry 2010, 67:940-947.